To evaluate and validate the incremental value of copeptin in the prediction of outcome and complications as compared with established clinical variables
Background. Stroke can be a challenging diagnosis in an emergency-setting. We sought to determine wh...
International audienceBACKGROUND:Copeptin - the C-terminal section of vasopressin precursor - is a n...
BACKGROUND: Grading of patients with aneurysmal subarachnoid hemorrhage (aSAH) is often confounded b...
RATIONALE: Copeptin independently predicts functional outcome and mortality at 90 days and one-year ...
RATIONALE: Copeptin independently predicts functional outcome and mortality at 90 days and one-year ...
OBJECTIVE: Early prediction of outcome in patients with ischemic stroke is important. Vasopressin is...
Background and Purpose—An accurate long-term outcome prediction may improve management of stroke pat...
BACKGROUND AND PURPOSE: Copeptin has been associated with recurrent cerebrovascular events after tra...
Background: Stroke is the second main cause of mortality and the third leading cause of mortality an...
OBJECTIVES To derive and externally validate a copeptin-based parsimonious score to predict unfav...
Abstract Background Copeptin is a new blood biomarker for acute ischemic stroke which emerged to ass...
To derive and externally validate a copeptin-based parsimonious score to predict unfavorable outcome...
Background and Purpose- Prognostic value of copeptin in acute ischemic stroke has been widely report...
Background C-terminal portion of provasopressin (copeptin) has recently been discussed as a novel...
Copyright © 2015 Johannes von Recum et al. This is an open access article distributed under the Crea...
Background. Stroke can be a challenging diagnosis in an emergency-setting. We sought to determine wh...
International audienceBACKGROUND:Copeptin - the C-terminal section of vasopressin precursor - is a n...
BACKGROUND: Grading of patients with aneurysmal subarachnoid hemorrhage (aSAH) is often confounded b...
RATIONALE: Copeptin independently predicts functional outcome and mortality at 90 days and one-year ...
RATIONALE: Copeptin independently predicts functional outcome and mortality at 90 days and one-year ...
OBJECTIVE: Early prediction of outcome in patients with ischemic stroke is important. Vasopressin is...
Background and Purpose—An accurate long-term outcome prediction may improve management of stroke pat...
BACKGROUND AND PURPOSE: Copeptin has been associated with recurrent cerebrovascular events after tra...
Background: Stroke is the second main cause of mortality and the third leading cause of mortality an...
OBJECTIVES To derive and externally validate a copeptin-based parsimonious score to predict unfav...
Abstract Background Copeptin is a new blood biomarker for acute ischemic stroke which emerged to ass...
To derive and externally validate a copeptin-based parsimonious score to predict unfavorable outcome...
Background and Purpose- Prognostic value of copeptin in acute ischemic stroke has been widely report...
Background C-terminal portion of provasopressin (copeptin) has recently been discussed as a novel...
Copyright © 2015 Johannes von Recum et al. This is an open access article distributed under the Crea...
Background. Stroke can be a challenging diagnosis in an emergency-setting. We sought to determine wh...
International audienceBACKGROUND:Copeptin - the C-terminal section of vasopressin precursor - is a n...
BACKGROUND: Grading of patients with aneurysmal subarachnoid hemorrhage (aSAH) is often confounded b...